AZ Donated Service Programme in Asthma

AstraZeneca is proud to support initiatives aimed at improving services and enhancing care for patients with Asthma. 

AstraZeneca offers Donated Goods and Services (DOGS) to support healthcare organisations:

  • Donated Services are services which are donated by AstraZeneca intended to improve an NHS service to enhance patient care (for example, capability, capacity, speed or quality of care).
  • Donated Services are and must always be non-promotional and must not be linked to promotion of a medicine.
  • Donated Services may be offered to healthcare organisations in the UK to deliver education and training to patients, staff or healthcare professionals (HCPs) in response to a specific need but may not be provided to individual HCPs for their personal benefit.

More information is contained within the ABPI Code of Practice

Details of Donated Goods and Service (DOGS) are publicly disclosed as transfer of value and are documented and kept on record by AstraZeneca.

 

Astrazeneca Donated Service: Identification of suspected severe asthma in adult patients in primary care (SPECTRA)

AstraZeneca is committed to improving person-centred health outcomes for those people living with asthma. Appropriate and timely review of patients with suspected severe asthma in specialist care supports improved outcomes by facilitating accurate diagnosis, the optimisation of adherence and the identification and control of comorbidities.  SPECTRA was developed to enable healthcare organisations (HCO) in primary care to identify suspected severe asthma in adult patients, this is a Donated Service Programme funded by AstraZeneca & developed in collaboration with NHS England & Improvement (NHSE&I) and the Accelerated Access Collaborative (AAC).

 

What is it?

Pre-defined searches have been developed to support primary care healthcare organisations to systematically and efficiently identify patients for review, optimisation of treatment and where appropriate referral to specialist centres.  SPECTRA primary care algorithm automates this procedure, searching a practice data system and enumerating lists of patients that fall into priority cohorts for review.  Healthcare organisations can then review patients identified within these lists and make clinical decisions on treatment modification and onward referral of appropriate patients.  This Donated Service Programme is funded by AstraZeneca and delivered by Oberoi Consulting.

 

Who is it for?

This Donated Service Programme funded by AstraZeneca & developed in collaboration with NHS England & Improvement (NHSE&I) and the Accelerated Access Collaborative (AAC) is unconditional and non-promotional and will be available on a first come first serviced basis to the NHS.

SPECTRA primary care clinical system resources have been developed to help primary care healthcare organisations improve the management of asthma.  The importable system search is available for SystemOne and EMIS Web, the two largest primary care clinical systems in the UK.  Both of these systems have inherent functionality which allows the import of pre-designed searches which may be used to interrogate a practice database without visiting the practice.

For Vision practices the searches can be deployed remotely into the GP system through an add on that is available to all practices - Vision+. Oberoi, as the third party provider, will work with Vision to notify them of the request to deploy the “pathway”.

FAQ

Can AstraZeneca see my practice data or any patient data?

By registering for SPECTRA the practice agrees to sharing of numerical aggregated data (NO PERSONAL OR PATIENT INFORMATION) with their PCN/Cluster, CCG/HSCP/UHB/AHSN and AstraZeneca.  Patient numbers between 1 and 7 are suppressed, aligned to NHS Digital's approach to suppression of small patient counts. None of the parties will be able to identify any patients from this data.

Who do I contact if I am having technical difficulties?

If you have any technical difficulties or wish to discuss IT governance please contact the AstraZeneca SPECTRA support team.

Telephone number: 01332 546909  Email: support@suspected-severe-asthma.co.uk


Application for this AstraZeneca Donated Service

If your HCO is interested in accessing SPECTRA, please make a request by registering interest on www.suspected-severe-asthma.co.uk.



VVPM ID: GB-32386  Date of Prep: December 2021